Sangart's Grant

Sangart raised a round of funding on October 05, 2010. Investors include U.S. Department of Defense.

Sangart is a biopharmaceutical company focused on oxygen-therapeutic agents, providing products to patients in need. Sangart was founded in 1998 based on discoveries arising from over two decades of …

Articles about Sangart's Grant: